Growth Metrics

Intelligent Bio Solutions (INBS) Total Non-Current Liabilities (2023)

Intelligent Bio Solutions has reported Total Non-Current Liabilities over the past 1 years, most recently at $5.7 million for Q4 2023.

  • Quarterly results put Total Non-Current Liabilities at $5.7 million for Q4 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $5.7 million (changed N/A YoY), and the annual figure for FY2023 was $6.7 million, changed.
  • Total Non-Current Liabilities for Q4 2023 was $5.7 million at Intelligent Bio Solutions, down from $6.7 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for INBS hit a ceiling of $6.7 million in Q2 2023 and a floor of $5.7 million in Q4 2023.